Literature DB >> 33509439

Epigenetic modifiers in normal and aberrent erythropoeisis.

Sriram Sundaravel1, Ulrich Steidl2, Amittha Wickrema3.   

Abstract

Erythroid differentiation program is comprised of lineage commitment, erythroid progenitor proliferation, and termination differentiation. Each stage of the differentiation program is heavily influenced by epigenetic modifiers that alter the epigenome in a dynamic fashion influenced by cytokines/humeral factors and are amicable to target by drugs. The epigenetic modifiers can be classified as DNA modifiers (DNMT, TET), mRNA modifiers (RNA methylases and demethylases) and histone protein modifiers (methyltransferases, acetyltransferases, demethylases, and deacetylases). Here we describe mechanisms by which these epigenetic modifiers influence and guide erythroid-lineage differentiation during normal and malignant erythropoiesis and also benign diseases that arise from their altered structure or function.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33509439      PMCID: PMC7883935          DOI: 10.1053/j.seminhematol.2020.12.005

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  135 in total

1.  Dnmt3a is essential for hematopoietic stem cell differentiation.

Authors:  Grant A Challen; Deqiang Sun; Mira Jeong; Min Luo; Jaroslav Jelinek; Jonathan S Berg; Christoph Bock; Aparna Vasanthakumar; Hongcang Gu; Yuanxin Xi; Shoudan Liang; Yue Lu; Gretchen J Darlington; Alexander Meissner; Jean-Pierre J Issa; Lucy A Godley; Wei Li; Margaret A Goodell
Journal:  Nat Genet       Date:  2011-12-04       Impact factor: 38.330

2.  Aberrant epigenetic and genetic marks are seen in myelodysplastic leukocytes and reveal Dock4 as a candidate pathogenic gene on chromosome 7q.

Authors:  Li Zhou; Joanna Opalinska; Davendra Sohal; Yiting Yu; Yongkai Mo; Tushar Bhagat; Omar Abdel-Wahab; Melissa Fazzari; Maria Figueroa; Cristina Alencar; Jinghang Zhang; Suman Kambhampati; Simrit Parmar; Sangeeta Nischal; Christoph Hueck; Masako Suzuki; Ellen Freidman; Andrea Pellagatti; Jacqueline Boultwood; Ulrich Steidl; Yogen Sauthararajah; Vijay Yajnik; Christine McMahon; Steven D Gore; Leonidas C Platanias; Ross Levine; Ari Melnick; Amittha Wickrema; John M Greally; Amit Verma
Journal:  J Biol Chem       Date:  2011-04-30       Impact factor: 5.157

3.  Distinct roles for TET family proteins in regulating human erythropoiesis.

Authors:  Hongxia Yan; Yaomei Wang; Xiaoli Qu; Jie Li; John Hale; Yumin Huang; Chao An; Julien Papoin; Xinhua Guo; Lixiang Chen; Qiaozhen Kang; Wei Li; Vincent P Schulz; Patrick G Gallagher; Christopher D Hillyer; Narla Mohandas; Xiuli An
Journal:  Blood       Date:  2017-02-06       Impact factor: 22.113

4.  Purification of human blood burst-forming units-erythroid and demonstration of the evolution of erythropoietin receptors.

Authors:  K Sawada; S B Krantz; C H Dai; S T Koury; S T Horn; A D Glick; C I Civin
Journal:  J Cell Physiol       Date:  1990-02       Impact factor: 6.384

Review 5.  Rethinking how DNA methylation patterns are maintained.

Authors:  Peter A Jones; Gangning Liang
Journal:  Nat Rev Genet       Date:  2009-09-30       Impact factor: 53.242

6.  Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies.

Authors:  Omar Abdel-Wahab; Ann Mullally; Cyrus Hedvat; Guillermo Garcia-Manero; Jay Patel; Martha Wadleigh; Sebastien Malinge; JinJuan Yao; Outi Kilpivaara; Rukhmi Bhat; Kety Huberman; Sabrena Thomas; Igor Dolgalev; Adriana Heguy; Elisabeth Paietta; Michelle M Le Beau; Miloslav Beran; Martin S Tallman; Benjamin L Ebert; Hagop M Kantarjian; Richard M Stone; D Gary Gilliland; John D Crispino; Ross L Levine
Journal:  Blood       Date:  2009-05-06       Impact factor: 22.113

7.  5-azacytidine selectively increases gamma-globin synthesis in a patient with beta+ thalassemia.

Authors:  T J Ley; J DeSimone; N P Anagnou; G H Keller; R K Humphries; P H Turner; N S Young; P Keller; A W Nienhuis
Journal:  N Engl J Med       Date:  1982-12-09       Impact factor: 91.245

8.  Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib.

Authors:  Eytan M Stein; Courtney D DiNardo; Amir T Fathi; Daniel A Pollyea; Richard M Stone; Jessica K Altman; Gail J Roboz; Manish R Patel; Robert Collins; Ian W Flinn; Mikkael A Sekeres; Anthony S Stein; Hagop M Kantarjian; Ross L Levine; Paresh Vyas; Kyle J MacBeth; Alessandra Tosolini; Jason VanOostendorp; Qiang Xu; Ira Gupta; Thomas Lila; Alberto Risueno; Katharine E Yen; Bin Wu; Eyal C Attar; Martin S Tallman; Stéphane de Botton
Journal:  Blood       Date:  2018-12-03       Impact factor: 25.476

9.  Histone deacetylase 6 regulates cytokinesis and erythrocyte enucleation through deacetylation of formin protein mDia2.

Authors:  Xuehui Li; Yang Mei; Bowen Yan; Eric Vitriol; Suming Huang; Peng Ji; Yi Qiu
Journal:  Haematologica       Date:  2017-03-02       Impact factor: 9.941

10.  Protein arginine methyltransferase 1 is required for maintenance of normal adult hematopoiesis.

Authors:  Lei Zhu; Xin He; Haojie Dong; Jie Sun; Hanying Wang; Yinghui Zhu; Feiteng Huang; Jingying Zou; Zexin Chen; Xiaoying Zhao; Ling Li
Journal:  Int J Biol Sci       Date:  2019-10-23       Impact factor: 6.580

View more
  1 in total

1.  Regulatory association of long noncoding RNAs and chromatin accessibility facilitates erythroid differentiation.

Authors:  Yunxiao Ren; Junwei Zhu; Yuanyuan Han; Pin Li; Jing Wu; Hongzhu Qu; Zhaojun Zhang; Xiangdong Fang
Journal:  Blood Adv       Date:  2021-12-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.